Results 241 to 250 of about 126,041 (267)

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study

Lancet, The, 2022
Tommy Nyberg, Neil Ferguson, Sophie G Nash   +2 more
exaly  

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Cell, 2022
Wanwisa Dejnirattisai, Jiandong Huo, Daming Zhou   +2 more
exaly  

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

Cell, 2022
Markus Hoffmann, Nadine Krüger, Cheila Rocha   +2 more
exaly  

Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2

Cell, 2022
Pengcheng Han, Zepeng Xu, Pu Han
exaly  

Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron

Cell, 2022
Zhen Cui, Nan Wang, Kaiyue Fan
exaly  

omicron, n.

2023
openaire   +1 more source

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees

Cell, 2022
Rungtiwa Nutalai, Daming Zhou, Aekkachai Tuekprakhon   +2 more
exaly  

Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike

Cell, 2022
Masami Morimatsu, Hesham Nasser, Jumpei Ito   +2 more
exaly  

Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study

Lancet, The, 2023
Robert B Gunier, Stephen Rauch, Sonia Deantoni   +2 more
exaly  

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

Nature, 2022
Adam Abdullahi, Niluka Goonawardane, Akatsuki Saito   +2 more
exaly